- Home
- MSEX vs EVMN Comparison
MSEX vs EVMN Comparison
Compare MSEX & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | EVMN |
|---|---|---|
| Founded | 1897 | 2020 |
| Country | United States | United States |
| Employees | 395 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 892.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MSEX | EVMN |
|---|---|---|
| Price | $54.31 | $24.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $60.33 | $44.17 |
| AVG Volume (30 Days) | 91.1K | ★ 988.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $10.94 | N/A |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.94 | $13.89 |
| 52 Week High | $67.09 | $33.20 |
Technical Indicators
Market Signals| Indicator | MSEX | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 49.61 |
| Support Level | $52.36 | $15.25 |
| Resistance Level | $54.65 | $33.20 |
| Average True Range (ATR) | 1.44 | 2.55 |
| MACD | -0.05 | -0.63 |
| Stochastic Oscillator | 49.40 | 27.75 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.